Pepdox
Studies
Peptides
Calculator
EBM BLS: Semaglutide Reduces Kidney Disease Progression in Patients with Type 2 Diabetes and Chronic Kidney Disease. | Pepdox
Home
/
Search
/
PMID 41251961
EBM BLS: Semaglutide Reduces Kidney Disease Progression in Patients with Type 2 Diabetes and Chronic Kidney Disease.
Journal of general internal medicine
2026
PMID: 41251961
View on PubMed
DOI: 10.1007/s11606-025-09906-8
Semaglutide
Authors
Alemu, Leah S; Narasimhan, Sweta; Alexander, Jason T
Keywords
chronic kidney disease
semaglutide
type 2 diabetes